Eli Lilly defeats billion-dollar claim over trade secrets

US pharmaceutical group Eli Lilly & Company has defeated a US$1.8 billion claim by a French biotech company that alleged it had misused trade secrets and confidential information.


Get unlimited access to all Global Arbitration Review content